Never Gonna Give You Up - Current Developments in Covalent Protein Kinase Inhibitors
Laura Hillebrand1, Matthias Gehringer2,3
1Department of Pharmaceutical & Medicinal Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany. laura.hillebrand@uni-tuebingen.de.
Abstract:
Covalent inhibitors have recently seen a revival in medicinal chemistry. Inhibitors addressing non-catalytic cysteine residues with weakly reactive electrophiles have been very successfully employed to target protein kinases, one of the major druggable protein families. Here we provide an overview of irreversible and reversible covalent protein kinase inhibitors in clinical development and beyond. We further spotlight recent advances in targeting amino acids other than cysteine and the reactive groups utilized in covalent protein kinase inhibitors.
Related Concept Videos
Protein Kinases and Phosphatases
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Inhibition of Cdk Activity
cAMP-dependent Protein Kinase Pathways
Protein-protein Interfaces
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...


